Clinical Trial Update: Efficacy and Safety of DEP114 in the Treatment of Moderate to Severe Persistent Allergic Rhinitis in Children. [Phase 3]

View source ↗

Summary

Phase 3 trial assessing DEP114 for efficacy and safety in children with moderate to severe persistent allergic rhinitis.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Allergic Rhinitis

Drugs mentioned

• DEP114

Snippet

Sponsor: EMS | Conditions: Allergic Rhinitis | Phase 3 | Status: NOT_YET_RECRUITING